Atara Biotherapeutics (ATRA) Exchange Rate Effect (2016)

Atara Biotherapeutics' (ATRA) quarterly Exchange Rate Effect came in at $38000.0 in Q2 2016, up 190.48% on a QoQ basis from -$42000.0 in Q1 2016.

Atara Biotherapeutics (ATRA) Exchange Rate Effect (2016) Analysis & Trends

Atara Biotherapeutics (ATRA) has 1 years of Exchange Rate Effect data on file, last reported at $38000.0 in Q2 2016.

Quarterly Exchange Rate Effect changed N/A year-over-year to $38000.0 in Q2 2016, while the trailing twelve-month figure through Jun 2017 was -$4000.0 (changed N/A YoY) and the FY2015 annual result came in at -$94000.0, changed N/A from the prior year.
Exchange Rate Effect climbed to $38000.0 in Q2 2016, from -$42000.0 in the prior quarter.
In the past five years, Exchange Rate Effect ranged from a high of $38000.0 in Q2 2016 to a low of -$42000.0 in Q1 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Exchange Rate Effect (Qtr)
1	Vertex Pharmaceuticals	139.95 Bn	132.10 Bn	2.84 Bn	-3.70 Mn
2	Regeneron Pharmaceuticals	86.71 Bn	78.72 Bn	3.93 Bn	-300,000.00
3	Argenx Se	65.71 Bn	60.52 Bn	1.37 Bn	-
4	Moderna	60.45 Bn	55.31 Bn	52.00 Mn	-2.00 Mn
5	BeOne Medicines	42.24 Bn	37.14 Bn	1.53 Bn	19.84 Mn
6	Alnylam Pharmaceuticals	31.80 Bn	28.49 Bn	992.69 Mn	-2.45 Mn
7	BioNTech SE	28.64 Bn	10.25 Bn	668.28 Mn	1.63 Mn
8	Insmed	27.61 Bn	26.45 Bn	358.27 Mn	-287,000.00
9	Royalty Pharma	27.26 Bn	26.42 Bn	-	-
10	Atara Biotherapeutics	142.96 Mn	126.41 Mn	439,000.00	-

Download Data